Elis announces final step in sale of Clinical Solutions

9 October 2019


Elis, an international multi-service provider, offering textile, hygiene and facility services solutions across Europe and Latin America, has signed an agreement to divest of 100% of the IHSS division of Clinical Solutions in the UK. The closing of the transaction is subject to certain legal and regulatory conditions and is expected to take place by the end of Q4 2019.

IHSS is one of the two divisions of Clinical Solutions, which was formerly owned by Berendsen until its acquisition by Elis in 2017. This division, based in the UK, provides decontamination and sterilization solutions for medical devices in the private and public Healthcare sector.

This activity posted revenues of around £19million in 2018.

The sale of IHSS completes the divestment of Clinical Solutions, which was split in two; the “Rocialle & Guardian” division was sold in August this year. In H1 2018, in a step to remain focused on its core business, Elis announced its intention to sell Clinical Solutions.


Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.